The effect of intravenous dexamethasone in supraclavicular brachial plexus block at Halibet National Referral Hospital, Eritrea 2024–2025: A randomized clinical trial
PLOS One · 2026
DOI: 10.1371/journal.pone.0338067 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, 2026. Verfasst von Michael Beraki Mengistu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, Anesthesia Unit, Orotta College of Medicine and Health Sciences, Asmara, Eritrea. Hauptthemen laut MEDLINE: Dexamethasone, Brachial Plexus Block, Postoperative Pain. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Postoperative pain has significant impact on recovery and healthcare costs. While effective regional anesthesia provides both anesthesia and analgesia, its effects are often of limited duration. Previous studies indicate that intravenous dexamethasone may enhance and prolong analgesia when used with regional blocks, yet reports on its duration to supraclavicular brachial plexus block (SCBPB) for upper limb surgeries are limited. We hypothesized that intravenous dexamethasone would extend postoperative analgesia following SCBPB.
Method
A randomized clinical trial was conducted at Halibet National Referral Hospital in Eritrea, involving 60 patients undergoing upper limb surgery who received SCBPB with 20 ml of 0.5% bupivacaine. Concurrently, the control group received 2 ml of normal saline, while the experimental group received 2 ml (8 mg) of intravenous dexamethasone. Pain scores, time to first rescue analgesia, and analgesic consumption were recorded. Data were analyzed using SPSS v26.
Results
The mean duration of analgesia was significantly longer in the dexamethasone group (17.36 ± 3.75 hours) compared to the control group (7.57 ± 1.04 hours, p < 0.001). The dexamethasone group had faster onset of sensory and motor block and lower analgesic consumption.
Conclusions
In summary, intravenous dexamethasone significantly prolonged postoperative analgesia, accelerated block onset, and reduced analgesic consumption without adverse events. These findings support its use as a practical adjunct to bupivacaine in supraclavicular brachial plexus block, with potential to improve postoperative pain management in low‑resource settings. Clinical trial registration This trial was registered in the Pan African Clinical Trial Registry (PACTR202509579633417). Participant recruitment occurred between September 23, 2024 and January 17, 2025, with follow‑up completed by January 18, 2025. The authors confirm that all ongoing and related trials for this intervention are registered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nursing, Anesthesia Unit, Orotta College of Medicine and Health Sciences, Asmara, Eritrea.
ORCID-Profile: Michael Beraki Mengistu
Zitieren
APA
Mengistu, M. B., Habtu, S. A., Elias, A. M., Idris, S. H., & Abraha, K. H. (2026). The effect of intravenous dexamethasone in supraclavicular brachial plexus block at Halibet National Referral Hospital, Eritrea 2024–2025: A randomized clinical trial. PLOS One. https://doi.org/10.1371/journal.pone.0338067
Vancouver
Mengistu MB, Habtu SA, Elias AM, Idris SH, Abraha KH. The effect of intravenous dexamethasone in supraclavicular brachial plexus block at Halibet National Referral Hospital, Eritrea 2024–2025: A randomized clinical trial. PLOS One. 2026. doi:10.1371/journal.pone.0338067
BibTeX
@article{Mengistu2026,
author = {Mengistu, Michael Beraki and Habtu, Senay Amare and Elias, Abel Mussie and Idris, Sabrina Hashim and Abraha, Kisanet Huruy},
title = {The effect of intravenous dexamethasone in supraclavicular brachial plexus block at Halibet National Referral Hospital, Eritrea 2024–2025: A randomized clinical trial},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0338067}
}
EUVIMED